Concepedia

Iris De Ryck

ID

Statistics

Publications

13

Citations

1.1K

H-Index

12

Active since

2008

Affiliations

GlaxoSmithKline (Belgium)(Current)

University of Antwerp

University of Maryland, Baltimore

Instituut voor Tropische Geneeskunde

Centre Pour le Développement des Vaccins-Mali

Iris De Ryck is an author at GlaxoSmithKline (Belgium) specializing in vaccinology, infectious diseases, and vaccination.

ORCID

Publications per year

2008–2024

13

Publications

13

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Katie Ewer, Tommy Rampling, Navin Venkatraman et al. · New England Journal of Medicine · 2015 · 356 citations · Full text

, , +14

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

Milagritos D. Tapia, Samba O. Sow, Kirsten E. Lyke et al. · The Lancet Infectious Diseases · 2015 · 216 citations · Full text

, , +14

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

Olga De Santis, R Audran, Emilie Pothin et al. · The Lancet Infectious Diseases · 2015 · 152 citations · Full text

, , +14

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, B Ndiaye et al. · The Lancet Infectious Diseases · 2020 · 76 citations · Full text

, , +14

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, Khardiata Diallo Mbaye et al. · The Lancet Infectious Diseases · 2020 · 64 citations

, , +14

1–5 of 13